Histogen Inc.
HSTODelisted Oct 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001383701
Histogen Inc. was delisted on Oct 12, 2023; its insiders filed their last Form 4 on Jun 21, 2023; 9 institutions reported holding it in 13F filings for Q3 2023, worth $9.53K in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Histogen Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 13
- −1 vs. Q1 2023
- Shares held
- 151.6K
- −23.2K (−13.3%) vs. Q1 2023
- Total value
- $107.8K
- −$103.3K (−48.9%) vs. Q1 2023
- New holders
- 2
- 2 more added
- Sold out
- 3
- 3 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HSTO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $6 |
| Q4 2023 | 1 | $5 |
| Q3 2023 | 9 | $9.53K |
| Q2 2023 | 13 | $107.8K |
| Q1 2023 | 14 | $211.1K |
| Q4 2022 | 13 | $90.4K |
| Q3 2022 | 13 | $174.0K |
| Q2 2022 | 10 | $229.0K |
| Q1 2022 | 23 | $1.00M |
| Q4 2021 | 25 | $2.76M |
| Q3 2021 | 22 | $2.15M |
| Q2 2021 | 24 | $2.99M |
| Q1 2021 | 26 | $2.18M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Histogen Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 60,166 | $42.8K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 34,910 | $24.8K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 16,100 | $11.4K | 0.00% | +16,100 | New |
| Two Sigma Securities, LLC | 10,491 | $7.46K | 0.00% | −2,332−18.2% | Reduced |
| Geode Capital Management, LLC | 10,249 | $7.30K | 0.00% | −138−1.3% | Reduced |
| Synovus Financial Corp | 10,050 | $7.15K | 0.00% | +10,050 | New |
| Tower Research Capital LLC (TRC) | 9,270 | $6.59K | 0.00% | +1,554+20.1% | Added |
| Advisor Group Holdings, Inc. | 275 | $196 | 0.00% | −100−26.7% | Reduced |
| Wells Fargo & Company | 31 | $22 | 0.00% | +1+3.3% | Added |
| Compagnie Lombard Odier SCmA | 15 | $11 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 15 | $11 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 15 | $0 | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −26,536−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −15,487−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −6,341−100.0% | Sold out |